|
Volumn 149, Issue 3, 1993, Pages 296-302
|
Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: Survey of five Canadian centres
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
DEXAMETHASONE;
LORAZEPAM;
METOCLOPRAMIDE;
ONDANSETRON;
PROCHLORPERAZINE;
ADULT;
AGED;
ARTICLE;
CANADA;
CANCER;
CANCER CHEMOTHERAPY;
CONTROLLED STUDY;
FEMALE;
HEALTH CARE COST;
HEALTH STATUS;
HEALTH SURVEY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
PRIORITY JOURNAL;
PROPHYLAXIS;
VOMITING;
ACTIVITIES OF DAILY LIVING;
ADULT;
AGED;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS;
COSTS AND COST ANALYSIS;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
MIDDLE AGED;
NAUSEA;
ONTARIO;
PROSPECTIVE STUDIES;
QUEBEC;
RISK FACTORS;
TIME FACTORS;
VOMITING;
|
EID: 0027246611
PISSN: 08203946
EISSN: 14882329
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (95)
|
References (0)
|